← Leaderboards
Mostafa A. Borahay
Johns Hopkins University
$4,836,095
Attributed
$6,445,282
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,445,282 · 2
By mechanism
R01$6,445,282 · 2
Top collaborators
- Jennifer Hartt Elisseeff3 shared
- James H. Segars3 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Saul J Sharkis$10,418,412
- Alan D Friedman$19,368,190
- Jennifer Hartt Elisseeff$18,978,528
- Maria E. Trent$10,876,537
- Joscelyn Claraluz Mejias$446,700
Others in their field
Other Emerging Leaders on “Uterine Fibroids”
- Kimberly A. Bertrand · Boston University Medical Campus$2,747,227
- Wei-Qi Wei · Vanderbilt University Medical Center$2,034,670
- Vanessa Jacoby · Theranova, Llc$1,478,077
- Andrew M Kelleher · Ut Southwestern Medical Center$1,317,825
- James H. Segars · Child Health And Human Development$1,298,744
- Daniel E Francis · Claria Medical, Inc.$1,256,000
Research focus
Uterine FibroidsExtracellular MatrixTissuesCellsXenograft ProcedureCell TypeIn VitroPublic HealthLeiomyomaPharmaceutical PreparationsResponseWomanFibroid TumorIn VivoGrowthClinical EffectSimvastatinSide EffectIncidenceUnited States National Institutes Of HealthFemaleFda ApprovedEvaluationCholesterol
Grant awards (9)
Role of senescent cells in uterine fibroid pathogenesis$791,630
R01 · FY2025 · HD
Role of senescent cells in uterine fibroid pathogenesis$803,402
R01 · FY2024 · HD
Role of senescent cells in uterine fibroid pathogenesis$818,748
R01 · FY2023 · HD
Mechanisms of actions(s) of simvastatin in uterine leiomyoma$704,878
R01 · FY2022 · HD · contact PI
Mechanisms of actions(s) of simvastatin in uterine leiomyoma$714,249
R01 · FY2021 · HD · contact PI
Mechanisms of actions(s) of simvastatin in uterine leiomyoma$300,000
R01 · FY2021 · HD · contact PI
Mechanisms of actions(s) of simvastatin in uterine leiomyoma$737,157
R01 · FY2020 · HD · contact PI
Mechanisms of actions(s) of simvastatin in uterine leiomyoma$743,831
R01 · FY2019 · HD · contact PI
Mechanisms of actions(s) of simvastatin in uterine leiomyoma$831,387
R01 · FY2018 · HD · contact PI